Contribution: Industrial Research Assistance Program – Contributions to Firms
DITU Inc.
$140,000.00
Smart Medical Device for Enhancing Myofascial Release from Increased COVID-19 Musculoskeletal Pains and Sports Related Injuries
FY 2021-22 · 2021-05-24
Summary
Quarantines from COVID-19 have been proven to cause an increase in musculoskeletal pain. Athletics and exercise are also common causes of this. Sidekick is developing 3 new medical devices to serve these demographics.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Edmonton|Edmonton, Alberta, Canada
Recipient Type
For-profit organization
Business Number
814180923
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-05-24 | 2021-22 | $80,000.00 |
| 1 | 2021-05-24 | 2021-22 | $120,000.00 |
| 2 | 2021-05-24 | 2021-22 | $140,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 20,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 20 000 dollars.
Agreement End Date
2022-05-31
Agreement Number
972437
Agreement Start Date
2021-05-24
Agreement Title
Smart Medical Device for Enhancing Myofascial Release from Increased COVID-19 Musculoskeletal Pains and Sports Related Injuries
Agreement Title (French)
Dispositif médical intelligent pour améliorer la libération myofasciale des douleurs musculo-squelettiques accrues liées à la COVID-19 et aux blessures causées par le sport
Agreement Type
Contribution
Agreement Value
$140,000.00
Amendment Date
2022-01-11
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Quarantines from COVID-19 have been proven to cause an increase in musculoskeletal pain. Athletics and exercise are also common causes of this. Sidekick is developing 3 new medical devices to serve these demographics.
Description (French)
Il a été prouvé que les quarantaines liées à la COVID-19 provoquent une augmentation des douleurs musculo-squelettiques. L'athlétisme et l'exercice physique en sont également des causes fréquentes. Sidekick est en train de concevoir 3 nouveaux dispositifs médicaux pour répondre à ces problèmes démographiques.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Edmonton Centre
Federal Riding (French)
Edmonton-Centre
Federal Riding Number
48014
NAICS Code
454110
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
814180923
Recipient City
Edmonton|Edmonton
Recipient Country
CA
Recipient Legal Name
DITU Inc.
Recipient Postal Code
T5G 0C9
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2021-2022-Q1-972437
